FDA.reportPublic FDA data

allogeneic processed thymus tissue-agdc 220 SQCM Drug Implant

RxCUI
2626464
RxNorm name
allogeneic processed thymus tissue-agdc 220 SQCM Drug Implant
Display name
allogeneic processed thymus tissue-agdc 220 SQCM Drug Implant
Full name
allogeneic processed thymus tissue-agdc 220 SQCM Drug Implant
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125685Rethymicallogeneic processed thymus tissue-agdc351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RETHYMICALLOGENIC THYMOCYTE-DEPLETED THYMUS TISSUE-AGDCSumitomo Pharma America, Inc.e0022c28-8cda-4f1e-bcf1-1f440d37ec4a2025-10-31Warnings, Adverse reactionsExact identifier
rxcui: 2626464

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
e0022c28-8cda-4f1e-bcf1-1f440d37ec4aallogeneic processed thymus tissue-agdc 220 SQCM Drug ImplantSCD8These highlights do not include all the information needed to use RETHYMIC safely and effectively. See full prescribing information for RETHYMIC. RETHYMIC (Allogeneic processed thymus tissue–agdc) For surgical implantation Initial U.S. Approval: 202120251031
e0022c28-8cda-4f1e-bcf1-1f440d37ec4aallogeneic processed thymus tissue-agdc 22,000 mm2 ImplantPSN8These highlights do not include all the information needed to use RETHYMIC safely and effectively. See full prescribing information for RETHYMIC. RETHYMIC (Allogeneic processed thymus tissue–agdc) For surgical implantation Initial U.S. Approval: 202120251031
e0022c28-8cda-4f1e-bcf1-1f440d37ec4aallogeneic processed thymus tissue-agdc 22,000 mm2 ImplantSY8These highlights do not include all the information needed to use RETHYMIC safely and effectively. See full prescribing information for RETHYMIC. RETHYMIC (Allogeneic processed thymus tissue–agdc) For surgical implantation Initial U.S. Approval: 202120251031